Morazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C23H27N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 870Q5BL2FN, chemically known as 1,2-dihydro-1,5-dimethyl-4-((3-methyl-2-phenyl-4-morpholinyl)methyl)-2-phenyl-3h-pyrazol-3-one but generally known as morazone, which bears US NIH Compound Identifier 39609. European Medicines Agency schedules Morazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09064MIG. The term MORAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). MORAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule morazone under HS 29349990 and SITC 51579. As of Q4 2014, MORAZONE remains the US FDA Preferred Term for this commodity. Morazone bears US NLM identifiers UMLS ID C0066795 and NCI Concept Code C66193. SMILES: O1C(C(N(CC1)CC1C(N(N(C1=O)C1CCCCC1)C)C)C)C1CCCCC1.